It’s possible that I shall make an ass of myself. But in that case one can always get out of it with a little dialectic. I have, of course, so worded my proposition as to be right either way (K.Marx, Letter to F.Engels on the Indian Mutiny)
Thursday, October 29, 2026
The masterminds hiding under the forest
Endophytes uncovered as keystone taxa shaping forest root microbiomes
Kyoto, Japan -- Beneath the forest floor extends a vast ecosystem where a diverse array of microorganisms inhabit soil and root systems. Here, fungi and bacteria play particularly pivotal roles in processes such as nutrient cycling and carbon sequestration. Within these microbial communities may exist a keystone species, which exerts a disproportionately large influence on the entire structure and function of such an ecosystem.
While scientists often associate a keystone species with conspicuous predators, pollinators, and plants, there is also a belief that the myriad microorganisms inhabiting the soil include 'hidden' key species. These may be crucial to understanding the dynamics of a complex ecological community, but identifying them within microbial environments is particularly daunting, as experimentally assessing the impact of any one particular species is impossible in a system as vast as a forest.
Fortunately, recent developments in DNA analysis technology have made it possible to capture the diversity of forest microorganisms as large-scale datasets. A team of researchers at Kyoto University was inspired to use this data to identify the masterminds hiding beneath the forest floor.
"Even a single plant root measuring less than one millimeter in diameter harbors a diverse array of coexisting microorganisms," says first author Mikihito Noguchi. "By identifying a keystone species, we aim to elucidate the mechanisms underlying the formation and maintenance of the microbial communities that support forest ecosystems from below."
The team collected 1,270 root samples from a cool-temperate forest in Sugadaira, Nagano prefecture, and analyzed DNA data from fungi and bacteria residing there. With this, they represented the microbial communities as one landscape by modeling the compositions they tend to adopt. This allowed the researchers to develop a theoretical framework to identify species that may be capable of dramatically altering the structure of the landscape: a resulting algorithm was fed to a supercomputer. Finally, the scientists compared their data from Nagano to a large dataset of forests in Europe to verify their findings across vast geographical distances.
Their results point toward a group of fungi known as endophytes, which symbiotically inhabit plant tissue and may play a key role in reshaping the symbiotic relationships between plants and microorganisms in the roots and soil. Endophytes had previously received little attention for their effect on forest ecosystems, but this study has revealed that these hidden masterminds significantly influence the landscape structure of fungal communities.
Further, the novel methods developed in this study serve as a versatile framework for identifying the crucial microorganisms that underpin the dynamics of other complex microbiomes, and have the potential for application in ecosystems far beyond the forest. In the future, these methods are expected to lead to management techniques that consider the ecosystem as a whole, including microbial communities.
###
The paper "Statistical inference of keystone taxa reshaping the assembly rules of forest root microbiomes" appeared on 28 October 2026 in Nature Communications, with doi: 10.1038/s41467-026-78401-3
About Kyoto University
Kyoto University is one of Japan and Asia's premier research institutions, founded in 1897 and responsible for producing numerous Nobel laureates and winners of other prestigious international prizes. A broad curriculum across the arts and sciences at undergraduate and graduate levels complements several research centers, facilities, and offices around Japan and the world. For more information, please see: http://www.kyoto-u.ac.jp/en
A new Global Burden of Disease (GBD) study in Neuroepidemiology looks closely at a striking contradiction in global stroke prevention: even as age-standardized stroke rates have fallen substantially over the past three decades, the number of people suffering and dying from stroke continues to rise.
Researchers led by Professor Valery L. Feigin of Auckland University of Technology estimate that in 2023, 13.2 million people experienced a new stroke, 6.8 million died, and almost 105 million were living with the effects of a previous stroke. Stroke remained the world's second leading cause of death and third leading cause of death and disability combined.
Between 1990 and 2023, age-standardized stroke mortality fell by 52%, disability-adjusted life year (DALY — a measure combining years of life lost to early death and years lived with disability) rates by 48%, and incidence by 25%. Yet over the same period, the absolute number of new strokes rose by 73%, deaths by 22%, and DALYs by 18%.
Population growth and aging explain part of the increase, but not all of it, said Feigin. "Stroke used to be called a disease of the elderly. That's no longer correct: 52% of strokes now happen in people of working age, under 70."
An estimated 1.9 million strokes now occur annually in people aged 15–49, a rise Feigin and his colleagues attribute to earlier, heavier exposure to metabolic risk factors, particularly poorly controlled blood pressure and childhood obesity trends now surfacing as adult hypertension and diabetes.
Uncontrolled hypertension remains the single largest driver of stroke worldwide, accounting for roughly 60% of the global burden. Yet about half of people prescribed blood-pressure medication stop taking it within months, often once their readings normalize, and only around 20% of people can feel the physical effects of elevated blood pressure. Feigin calls it "a silent killer"; many people don't know anything is wrong until they have a stroke or heart attack.
High ambient temperature is also emerging as a major, underappreciated contributor: its share of the stroke burden rose 122% between 1990 and 2023, accounting for more than 2.2 million DALYs in 2023 alone, concentrated in North and Central Africa, the Middle East, and South Asia. Low temperature carries risk too, Feigin noted, particularly in regions historically accustomed to warmth, where cold snaps are now linked to higher rates of stroke and heart attack.
Feigin argues the field has leaned too heavily on a "high-risk" prevention strategy, screening people and treating only those found to be at elevated cardiovascular risk.
"Even in a best-case scenario, treating high-risk individuals only prevents around 11% of strokes and heart attacks, because roughly 80% of strokes occur in people classified as low or moderate risk," he said. Recent reviews of randomized controlled trials, he added, found that risk screening alone, without follow-up action, produces no meaningful reduction in events.
Instead, he favors pairing population-wide measures, including salt reduction, taxes on sugary drinks, and tobacco control, with individual prevention through digital tools like smartphone risk-assessment apps, which can reach people at any level of risk.
"We need a strategy that treats everyone with even one elevated risk factor, not just those who cross a high-risk threshold. Otherwise, we are heading toward a crisis health systems will struggle to absorb," he said.
Global inequalities remain stark: more than 80% of stroke deaths and DALYs occur in low- and middle-income countries, where rising exposure to risk factors — not population aging — is the dominant driver of increasing stroke numbers.
The Latest Global Stroke Fact Sheet 1990–2023: Global Burden of Disease Study was published in Neuroepidemiology on 7 May 2026. DOI: 10.1159/000552065.
About Karger Publishers
Connecting people and science since 1890, Karger provides scientists, healthcare professionals, patients, and the broader public with reliable and tailored information in Health Sciences. Building upon a publishing portfolio of more than 100 reputable scholarly journals and the award-winning Fast Facts medical info series, Karger excels in
The majority of DDI countries fall into the medium dependency category (yellow). There are some countries with low dependency (blue) and some with high dependency (purple).
Dependence on digital technologies in the European Union continues to grow—despite all calls for greater digital sovereignty. Between 2010 and 2023, Europe’s “Digital Dependence Index” (DDI) rose by 0.5 percentage points, while China reduced its dependence by nearly 11 percentage points and the U.S. by 6 percentage points. A major weakness lies in digital platforms, where European countries are almost entirely dependent on foreign providers. This is according to a policy study by the Vodafone Institute and the Center for Advanced Security, Strategic and Integration Studies (CASSIS) at the University of Bonn.
Despite numerous initiatives to strengthen technological autonomy, Europe became more dependent on digital technologies from abroad between 2010 and 2023—according to a new study by the Vodafone Institute and the University of Bonn. The policy study “Getting Strategic Priorities Right – Towards a Framework for Reducing Digital Dependencies” is the result of a year-long collaboration between the Vodafone Institute and the Center for Advanced Security, Strategic and Integration Studies (CASSIS) at the University of Bonn.
The University of Bonn’s “Digital Dependence Index,” on which the study is based, compares 51 countries—including 16 European countries—across four dimensions: trade in information and communication technology (ICT) goods, trade in ICT services, digital platforms, and ICT patents. The study highlights how countries’ dependence on foreign digital technologies changed annually between 2010 and 2023.
Moderate to High Level of Digital Dependence
Europe’s digital dependence increased by about 0.5 percentage points overall during this period. In comparison, China reduced its dependence by nearly 11 percentage points, and the United States by 6 percentage points. Throughout the period under review, European countries consistently exhibited moderate to high levels of digital dependence. Their greatest vulnerability lay in the area of digital platforms, where European countries were almost entirely dependent on foreign providers.
Between 2010 and 2023, the largest percentage point increases in digital dependence were recorded in Finland (13.7), Sweden (7.2), Norway (6.4), Estonia (3.9), and France (3.1). The sharpest declines in Europe were observed in Serbia (−17.3), the Czech Republic (−5.5), Poland (−4.2), and the United Kingdom (−3.5). Europe also remained highly dependent on foreign ICT patents. This limits its ability to capitalize on the economic and strategic benefits of technological innovations.
Joakim Reiter, Vodafone Group Chief External & Corporate Affairs Officer said: “Europe has spent years deliberating on digital sovereignty, but the evidence shows that its underlying dependence remains high. While the United States and China have strengthened their positions, Europe has fallen slightly further in the wrong direction. Europe has significant industrial, research and engineering strengths, but it needs to decide where those strengths can make the greatest difference. That means setting clear priorities, coordinating action across borders and sustaining investment beyond individual political cycles.”
No Uniform Dependency Profile
The study shows that European countries do not have a uniform dependency profile. They exhibit different capabilities and vulnerabilities. Therefore, a uniform Europe-wide policy does not appear advisable. Furthermore, the study shows that previous political efforts to achieve greater technological autonomy were too ambitious.
Maximilian Mayer, Professor for International Relations and Global Politics of Technology at the University of Bonn said: “Although European governments have implemented various policies and measures to foster digital sovereignty, their efforts have not been ambitious enough. One of the key problems is clearly the lack of strategic priorities for increasing digital capabilities and addressing digital dependencies.” Mayer’s CASSIS colleague Dr. Laura Mahrenbach adds: “Setting priorities isn’t enough on its own. To achieve those priorities, Europe needs to be smart in implementing digital resilience measures and engage more with international strategic partners.”
Four Policy Pathways
The researchers identify four evidence-based policy pathways, some of which can be combined:
• Building indispensable positions in the supply chain: Strengthening Europe’s existing industrial and technological capacities. • Creating a European technology powerhouse: Making substantial investments in a competitive European approach, including platforms, infrastructure, patents, and homegrown technology companies. • Addressing the most serious vulnerabilities: Identifying and eliminating critical technological bottlenecks, particularly where security and essential government functions are at stake. • Diversification: Reducing excessive dependence on a small number of foreign suppliers by expanding European capabilities and forging new international technology partnerships.
The study recommends that European policymakers agree on common strategic priorities as soon as possible. They should also coordinate regulation, innovation, investment, and procurement across national borders and align short-, medium-, and long-term measures. It is also crucial to launch a long-term public debate on the benefits of greater digital resilience.
Website for the “Digital Dependence Index”
In addition to the study, an interactive website for the “Digital Dependence Index” – https://digitaldependence.eu/ – allows users to track changes in digital dependencies in detail. Policy makers, researchers, businesses, and the general public can use it to compare countries and regions, examine changes in country profiles over time, and view the underlying data. It also includes an AI-powered tool designed to help users navigate the dataset and understand its political context.
Dr. Maximilian Mayer Junior Professor of International Relations and Global Politics of Technology Center for Advanced Security, Strategic and Integration Studies (CASSIS) University of Bonn Tel. +49 (0)228/73 5640 Email: maximilian.mayer@uni-bonn.de
Method of Research
Data/statistical analysis
Subject of Research
Not applicable
Article Title
Getting Strategic Priorities Right – Towards a Framework for Reducing Digital Dependencies
Article Publication Date
28-Oct-2026
Francis Peyton Rous: The discovery that laid the foundations of viral oncology
“Rous is credited for identifying a transmissible agent responsible for sarcoma in chickens, a discovery that laid the foundation for the field of viral oncology”
The review explores the life and scientific achievements of Francis Peyton Rous, whose pioneering experiments demonstrated that a cancer-causing agent could be transmitted between chickens. His discovery challenged established ideas about cancer and helped lay the foundation for viral oncology, oncogene research and the modern understanding of cancer as a genetic disease. The article also examines his contributions to blood preservation, experimental carcinogenesis and scientific publishing.
Today, scientists recognize that certain viruses can contribute to cancer development by altering cellular signaling, interfering with tumor-suppressor pathways or promoting chronic inflammation. However, at the beginning of the twentieth century, cancer was largely considered a disease arising from abnormalities within cells rather than infectious agents. Rous's research helped transform this understanding by demonstrating that an external biological agent could initiate malignant tumor formation.
Born in Baltimore, Maryland, in 1879, Rous developed an early interest in natural history and scientific observation. He studied at Johns Hopkins University, earning his medical degree in 1905, and later pursued pathology research at the University of Michigan and further training in Germany. His scientific approach was shaped by mentors who emphasized careful observation, accurate diagnosis and experimental rigor.
In 1909, Rous joined the Rockefeller Institute for Medical Research, where he was asked to investigate cancer. That same year, a poultry farmer brought him a Barred Plymouth Rock hen with a breast tumor. Rous examined the growth and identified it as a spindle-cell sarcoma, an aggressive malignancy arising from connective tissue.
What began as the examination of an unusual chicken tumor developed into experiments that would change cancer biology. Rous initially transplanted tumor tissue into other chickens, observing successful growth in genetically related birds but not in unrelated animals. These findings highlighted the importance of host compatibility and encouraged further investigation into how the tumor could spread.
The decisive breakthrough came when Rous tested whether tumor transmission required living cancer cells. He ground tumor tissue in solution, separated the liquid component and passed it through a Berkefeld filter designed to retain bacteria and intact cells. When the resulting cell-free filtrate was injected into healthy chickens of a closely related strain, new tumors developed.
These experiments, reported in 1910–1911, demonstrated that a filterable agent could transmit malignant disease without transferring intact tumor cells. The agent was later identified as Rous sarcoma virus (RSV), an avian retrovirus capable of transforming infected cells into cancer cells.
The discovery challenged prevailing assumptions about cancer. Although Rous could not identify the virus using modern molecular techniques, his experiments established a new explanation for how certain malignancies could arise.
Despite the significance of his findings, many scientists remained skeptical. No human cancer had yet been conclusively linked to a virus, and researchers questioned whether observations in chickens were relevant to human disease. Limited experimental technologies also made it difficult to explain how the agent caused tumors. Rous nevertheless maintained confidence in his observations, supported by careful documentation and reproducible evidence.
During the years when his cancer research received limited recognition, Rous expanded his investigations into other medical fields. Working with J. R. Turner during 1915–1916, he developed the Rous–Turner solution, a citrate-sugar preparation that allowed red blood cells to be preserved for extended periods.
This innovation contributed to the development of blood storage and transfusion practices, including early wartime blood banks. Although the original formulation was later replaced, its principles of citrate anticoagulation and glucose-supported red blood cell preservation remain important in modern transfusion medicine.
Rous also returned to cancer research through studies of rabbit papillomaviruses and chemical carcinogenesis. His investigations examined how viral infection and chemical agents could interact during tumor development. In work with William F. Friedewald in 1944, he helped clarify the distinction between tumor initiation and promotion, contributing to the understanding that cancer develops through multiple biological stages.
Meanwhile, advances in cell culture and molecular biology began revealing the broader significance of RSV. In the 1950s, Howard Temin and Harry Rubin developed experimental assays that allowed researchers to measure virus-induced cellular transformation in culture. These methods moved tumor virology beyond animal experiments and made the underlying mechanisms easier to investigate.
Another breakthrough came with the discovery of reverse transcriptase by Temin and David Baltimore in 1970. This enzyme allows retroviruses to convert RNA into DNA, which can then integrate into the host genome. The finding explained a fundamental step in retroviral replication and helped researchers understand how viral genetic information could persist within infected cells.
Subsequent research identified the v-src gene as the transforming oncogene carried by RSV. Scientists later discovered that this viral gene was related to c-src, a normal cellular gene involved in regulating growth and signaling. This established a fundamental principle of cancer biology: genes that normally regulate cellular functions can become oncogenic when altered or improperly controlled.
Further investigations demonstrated that Src functions as a tyrosine kinase, an enzyme involved in transmitting signals that regulate cell growth, survival and other activities. These discoveries helped establish the importance of oncogenes, proto-oncogenes and abnormal signaling pathways in cancer development, providing a foundation for later advances in molecular oncology.
The review also traces how tumor virology contributed to understanding human cancers associated with infectious agents. Subsequent research identified cancer-related viruses, including human papillomavirus (HPV), hepatitis B virus (HBV), Epstein–Barr virus (EBV), human T-lymphotropic virus type 1 (HTLV-1) and Kaposi's sarcoma-associated herpesvirus (KSHV).
These discoveries contributed to cancer prevention and treatment strategies, particularly vaccination against HPV and HBV, which can prevent infections responsible for certain malignancies. However, the review presents Rous's contribution as foundational rather than suggesting that his original experiments directly produced modern therapies.
Recognition of Rous's achievement came decades after his initial discovery. In 1966, at the age of 87, he received the Nobel Prize in Physiology or Medicine for demonstrating that a filterable agent could induce malignant tumors in chickens. He shared the award with Charles Huggins, whose work established the hormonal responsiveness of prostate cancer.
The Nobel Prize came approximately 55 years after Rous's landmark experiments, reflecting the prolonged skepticism surrounding viral carcinogenesis. By then, RSV had become an important experimental model for cancer research, while later discoveries involving reverse transcriptase and the src oncogene further clarified the molecular mechanisms of cancer.
Beyond his laboratory research, Rous influenced biomedical publishing through his work at the Journal of Experimental Medicine. Beginning as co-editor in 1921, he later served as editor and remained involved until 1970. His commitment to clear scientific communication, experimental rigor and accurate attribution helped shape the journal and influence generations of researchers.
“What began with the investigation of a tumor-bearing chicken at the Rockefeller Institute therefore contributed to a chain of discoveries that profoundly changed our understanding of cancer biology and its molecular basis.”
The review highlights broader lessons from Rous's career, including the importance of scientific preparedness, meticulous recordkeeping, intellectual flexibility and persistence. His willingness to investigate an unexpected observation, despite limited technology and professional skepticism, demonstrates how careful experimentation can challenge established assumptions and open new research directions.
As a historical and scientific review, the article synthesizes historical accounts and subsequent research developments rather than presenting new experimental findings. The authors emphasize that Rous's original discovery became the starting point for a broader scientific effort involving many investigators who helped establish the molecular basis of cancer.
Overall, the review presents Francis Peyton Rous as a pioneering scientist whose curiosity, persistence and experimental rigor transformed cancer research. His demonstration that a filterable agent could cause malignant tumors established a foundation for viral oncology and the discovery of cellular oncogenes. More than a century later, his legacy continues to influence research into cancer mechanisms, prevention and molecularly targeted therapies.